2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021

Diffuse Hormonal Systems - Endotext - NCBI Bookshelf

Chapters Archive - Page 11 of 44 - Endotext

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future in: Endocrine-Related Cancer Volume 23 Issue 12 (2016)

Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas

Can immediate postoperative random growth hormone levels predict long-term cure in patients with acromegaly? Dutta P, Korbonits M, Sachdeva N, Gupta P, Srinivasan A, Devgun JS, Bajaj A, Mukherjee KK Neurol India

pasireotide

Frontiers Interpreting growth hormone and IGF-I results using modern assays and reference ranges for the monitoring of treatment effectiveness in acromegaly

Secondary diabetes mellitus in acromegaly

86th Annual Meeting of the American Thyroid Association

2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021

Physiopathology, Diagnosis, and Treatment of GH Hypersecretion

Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma